- Patent Title: Muscle stem cell or myoblast, method for screening substances that participate in metabolic conversion using same, and pharmaceutical composition comprising substance obtained from said screening method
-
Application No.: US15031491Application Date: 2014-10-24
-
Publication No.: US09568469B2Publication Date: 2017-02-14
- Inventor: Kazuhiro Shigemoto
- Applicant: TOKYO METROPOLITAN GERIATRIC HOSPITAL AND INSTITUTE OF GERONTOLOGY
- Applicant Address: JP Tokyo
- Assignee: Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology
- Current Assignee: Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology
- Current Assignee Address: JP Tokyo
- Agency: Heslin Rothenberg Farley & Mesiti PC
- Agent Teige P. Sheehan
- Priority: JP2013-221037 20131024
- International Application: PCT/JP2014/078366 WO 20141024
- International Announcement: WO2015/060430 WO 20150430
- Main IPC: G01N33/50
- IPC: G01N33/50 ; A61K31/436 ; A61K45/06 ; A61K31/198 ; A61K31/36 ; A61K38/18 ; A61K38/20 ; A61K38/00

Abstract:
The object of the present invention is to provide a method for screening a substance involved in a metabolic shift of skeletal muscle, and a kit for screening a substance involved in a metabolic shift of skeletal muscle.The object can be solved by a muscle stem cell or myoblast comprising at least one myosin-heavy chain fusion gene selected from the group consisting of a myosin-heavy chain I fusion gene wherein a myosin-heavy chain I gene and a fluorescent protein or photoprotein gene are fused, a myosin-heavy chain IIa fusion gene wherein a myosin-heavy chain IIa gene and a fluorescent protein or photoprotein gene are fused, a myosin-heavy chain IId/x fusion gene wherein a myosin-heavy chain IId/x gene and a fluorescent protein or photoprotein gene are fused, and a myosin-heavy chain IIb fusion gene wherein a myosin-heavy chain IIb gene and a fluorescent protein or photoprotein gene are fused.
Public/Granted literature
Information query
IPC分类: